Health Trials

Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

2

Review clinical trials related to Advanced or Metastatic Squamous Non-Small Cell Lung Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

This is a randomized, open-label, multi-center, global phase II/III clinical study to evaluate the efficacy and safety of HLX43 monotherapy or HLX43 in combination with HLX07 vs. docetaxel in the treatment of advanced squamous NSCLC after failure of first-line treatment.

Participants needed: 706
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Henlius BiotechUpdated: Jun 1, 2026Locations: 1
Eligibility criteria

Have a full understanding of the study content, process, and possible adverse re... [+6]

Histologically or cytologically confirmed tumor containing components of small c... [+8]

Read more
Status: Recruiting

A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers

This is a Phase Ib/II multi-center, open-label study of HMBD-001 in combination with cetuximab with or without docetaxel in participants with advanced Squamous Cell Cancers

Participants needed: 398
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Hummingbird BioscienceUpdated: May 27, 2026Locations: 20
Eligibility criteria

Ability to understand and be willing to sign an informed consent form [+9]

Prior treatment with HMBD-001, docetaxel, cetuximab or any other agent that targ... [+14]

Read more